Economic analysis of paliperidone long-acting injectable for chronic schizophrenia in Portugal.

Item

http://www.wikidata.org/entity/Q52800015

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Economic analysis of paliperid ...... nic schizophrenia in Portugal.

@en

Economic analysis of paliperid ...... nic schizophrenia in Portugal.

@nl

type

Item

label

Economic analysis of paliperid ...... nic schizophrenia in Portugal.

@en

Economic analysis of paliperid ...... nic schizophrenia in Portugal.

@nl

prefLabel

Economic analysis of paliperid ...... nic schizophrenia in Portugal.

@en

Economic analysis of paliperid ...... nic schizophrenia in Portugal.

@nl

P1476

Economic analysis of paliperid ...... nic schizophrenia in Portugal.

@en

P2093

Basil G Bereza

http://www.w3.org/2001/XMLSchema#string

Kristel Van Impe

http://www.w3.org/2001/XMLSchema#string

Pushpendra Goswami

http://www.w3.org/2001/XMLSchema#string

Susana Maia-Lopes

http://www.w3.org/2001/XMLSchema#string

Thomas R Einarson

http://www.w3.org/2001/XMLSchema#string

P2860

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia

Rehospitalization rates of chronically ill schizophrenic patients discharged on a regimen of risperidone, olanzapine, or conventional antipsychotics.

Worldwide-Schizophrenia Outpatient Health Outcomes (W-SOHO): baseline characteristics of pan-regional observational data from more than 17,000 patients.

Systematic meta-review of depot antipsychotic drugs for people with schizophrenia.

A controlled, evidence-based trial of paliperidone palmitate, a long-acting injectable antipsychotic, in schizophrenia.

Psychiatric disorders and repeat incarcerations: the revolving prison door.

Routine HIV screening in Portugal: clinical impact and cost-effectiveness.

Partial compliance and risk of rehospitalization among California Medicaid patients with schizophrenia.

Paliperidone palmitate in non-acute patients with schizophrenia previously unsuccessfully treated with risperidone long-acting therapy or frequently used conventional depot antipsychotics.

Paliperidone palmitate and risperidone long-acting injectable in subjects with schizophrenia recently treated with oral risperidone or other oral antipsychotics.

P304

913-921

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/13696998.2016.1184156

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-04-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27124697

http://www.w3.org/2001/XMLSchema#string

P921

schizophrenia

Portugal